We are live on ! Find out more
MGNX icon

MacroGenics

109 hedge funds and large institutions have $125M invested in MacroGenics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,264% more call options, than puts

Call options by funds: $600K | Put options by funds: $44K

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

94% more capital invested

Capital invested by funds: $64.2M → $125M (+$60.6M)

24% more funds holding

Funds holding: 88109 (+21)

4.87% more ownership

Funds ownership: 63.05%67.92% (+4.9%)

4% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 28

Holders
109
Holders Change
+21
Holders Change %
+23.86%
% of All Funds
1.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
29
Reduced
28
Closed
9
Calls
$600K
Puts
$44K
Net Calls
+$556K
Net Calls Change
+$432K

MGNX Hedge Fund Activity: Q1 2026 in Review

109 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2026, worth a combined $125M — up 94% from $64.2M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MGNX positions and 9 closed out — a net gain of 23 holders — while 29 added to existing stakes and 28 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $3.98M. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $2.96M sold.

  • 109 institutional investors held MacroGenics (MGNX) as of Q1 2026, up from 88 in Q4 2025.
  • Funds reported $125M of MacroGenics stock for Q1 2026, up 94% quarter-over-quarter.
  • 32 funds opened new MacroGenics positions in Q1 2026 and 9 closed out, a net change of +23 holders.
  • The largest MacroGenics buyer in Q1 2026 was RA Capital Management, an estimated $3.98M added.
  • The largest MacroGenics seller in Q1 2026 was Jefferies Financial Group, an estimated $2.96M sold.

Based on aggregated 13F filings for Q1 2026.